Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18 Hold
6
﹤0.01% 1257
2026
Q1
$19 Sell
6
-2
-25% -$8 ﹤0.01% 1098
2025
Q4
$37 Buy
+8
New +$33 ﹤0.01% 1083
2020
Q2
Sell
-25
Closed 539
2020
Q1
$0 Buy
+25
New +$373 ﹤0.01% 752
2018
Q1
Sell
-43
Closed -$1K 295
2017
Q4
$1K Buy
+43
New +$1.17K ﹤0.01% 851

Other funds holding CLLS

Inspire Investing's CLLS Position: Q2 2026 in Review

Inspire Investing held its Cellectis (CLLS) position steady in Q2 2026 at 6 shares worth $18. The position accounts for ﹤0.01% of the portfolio, ranked #1257.

Inspire Investing first reported a position in CLLS in Q4 2017 and has held it in 5 quarters since. The position peaked at $1K in Q4 2017. 27 funds tracked by Wall St. Rank hold CLLS as of Q2 2026.

  • Inspire Investing held 6 shares of Cellectis worth $18 as of Q2 2026.
  • Inspire Investing left its Cellectis share count unchanged in Q2 2026.
  • Cellectis made up ﹤0.01% of Inspire Investing's portfolio in Q2 2026, its #1257 holding.
  • Inspire Investing first reported a position in Cellectis in Q4 2017 and has held it in 5 quarters since.
  • Inspire Investing's Cellectis position peaked at $1K in Q4 2017.
  • 27 funds tracked by Wall St. Rank held Cellectis as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.